VRTX Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.
$268.45 +9.86 (3.81%)
As of 05/23/2022 15:59:59 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 03/08/2001
Outstanding shares: 255,755,961
Average volume: 1,828,635
Market cap: $65,332,860,237
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: 2931034
Valuation (See tab for details)
PE ratio: 26.98
PB ratio: 6.06
PS ratio: 8.22
Return on equity: 22.47%
Net income %: 30.84%